Author:
Diaby Vakaramoko,Goeree Ron
Reference54 articles.
1. Bowen JM, Patterson LL, O’Reilly D, et al. Conditionally funded field evaluations and practical trial design within a health technology assessment framework. J Am Coll Radiol. 2009;6:324–31.
2. Briggs A, Ritchie K, Fenwick E, et al. Access with evidence development in the UK: past experience, current initiatives and future potential. Pharmacoeconomics. 2010;28:163–70.
3. Carlson JJ, Sullivan SD, Garrison LP, et al. Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers. Health Policy. 2010;96:179–90.
4. Centers for Medicare and Medicaid Services. National coverage determinations with data collection as a condition of coverage: coverage with evidence development. Baltimore: Centers for Medicare and Medicaid Services; 2006.
http://www.cms.gov/Medicare/Coverage/DeterminationProcess/Downloads/ced.pdf
. Accessed 8 July 2012.
5. Chalkidou K, Hoy A, Littlejohns P. Making a decision to wait for more evidence: when the National Institute for Health and Clinical Excellence recommends a technology only in the context of research. J R Soc Med. 2007;100:453–60.